Health
Common blood-thinning drug emerges as potential therapeutic treatment during Covid – Times of India
A common blood-thinning drug — Low Molecular Weight Heparin (LMWH) — has emerged as a potential therapeutic treatment for Covid-19 patients. Doctors said the drug — as a subcutaneous injection — has helped reduce hospitalisation periods, improved recovery ra…
Aug 30, 2020, 03:44PM ISTSource: TOI.inA common blood-thinning drug Low Molecular Weight Heparin (LMWH) has emerged as a potential therapeutic treatment for Covid-19 patients. Doctors said the drug as a subcutaneous injection has helped reduce hospitalisation periods, improved recovery rate and has significantly cut the rate of sudden deaths by over 90%. Encouraged by the outcomes, specialists TOI spoke to said doctors nationwide were now using the drug as a prophylactic (preventive) therapy to …
-
Business21 hours agoWhere will Berkshire Hathaway be in 1 year?
-
Noosa News24 hours agoNick Cave and The Bad Seeds Are Bringing Their ‘Wild God’ Tour to Australia and New Zealand in 2026
-
Noosa News16 hours agoTwo trapped and fighting for life after major three-vehicle crash in Brisbane
-
Business23 hours agoWhat’s Bell Potter’s take on Endeavour Group shares following earnings results?